Risk Factors of Diabetic Foot Charcot Arthropathy: a Case-control Study at a Malaysian Tertiary Care Centre

Overview

Journal Singapore Med J

Specialty General Medicine

Date 2016 Apr 15

PMID 27075668

Citations 17

Authors

Aishah Ahmad Fauzi

Tze Yang Chung

Lydia Abdul Latif

Affiliations

Soon will be listed here.

Abstract

Introduction: This study aimed to determine the risk factors of diabetic Charcot arthropathy of the foot among diabetic patients with and without foot problems.

Methods: This was a case-control study involving diabetic patients attending the Diabetic Foot Care and Wound Management Clinic at University Malaya Medical Centre, Kuala Lumpur, Malaysia, from June 2010 to June 2011. Data on sociodemographic profiles, foot factors and diabetes characteristics was collected and analysed.

Results: A total of 48 diabetic patients with Charcot arthropathy of the foot were identified. Data from these 48 patients was compared with those of 52 diabetic patients without foot problems. Up to 83.3% of patients with diabetic Charcot arthropathy presented with unilateral Charcot foot, most commonly located at the midfoot (45.8%). Patients with a history of foot problems, including foot ulcer, amputation, surgery or a combination of problems, had the highest (26-time) likelihood of developing Charcot arthropathy (odds ratio 26.4; 95% confidence interval 6.4-109.6). Other significant risk factors included age below 60 years, more than ten years' duration of diabetes mellitus and the presence of nephropathy.

Conclusion: A history of prior diabetic foot problems is the greatest risk factor for developing diabetic Charcot arthropathy, compared with other risk factors such as diabetes characteristics and sociodemographic profiles. Preventive management of diabetic foot problems in the primary care setting and multidisciplinary care are of paramount importance, especially among chronic diabetic patients.

Citing Articles

Risk factors for Charcot foot development in individuals with diabetes mellitus.

Tsatsaris G, Ekberg N, Fall T, Catrina S Diabetologia. 2024; 67(12):2702-2710.

PMID: 39271519 PMC: 11604682. DOI: 10.1007/s00125-024-06271-9.

What the Physician Needs to Know about Charcot Arthropathy and Ankle Fracture Treatment Dilemma: A Case Report and a Possible Medical Approach and Treatment Algorithm.

Tsatlidou M, Vasiliadis A, Metaxiotis D J Orthop Case Rep. 2024; 14(6):45-51.

PMID: 38910990 PMC: 11189088. DOI: 10.13107/jocr.2024.v14.i06.4498.

Charcot Neuroarthropathy of the Foot and Ankle in the Acute Setting: An Illustrative Case Report and Targeted Review.

Bagheri K, Anastasio A, Krez A, Siewny L, Adams S West J Emerg Med. 2023; 24(5):921-930.

PMID: 37788033 PMC: 10527838. DOI: 10.5811/westjem.59833.

Development of predictive nomograms clinical use to quantify the risk of diabetic foot in patients with type 2 diabetes mellitus.

Peng B, Min R Front Endocrinol (Lausanne). 2023; 14:1186992.

PMID: 37388212 PMC: 10304289. DOI: 10.3389/fendo.2023.1186992.

Diabetic Foot Considerations Related to Plantar Pressures and Shear.

Martin J, Davis B Foot Ankle Clin. 2023; 28(1):13-25.

PMID: 36822683 PMC: 10111339. DOI: 10.1016/j.fcl.2022.11.004.

References

Mabilleau G, Petrova N, Edmonds M, Sabokbar A . Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand. Diabetologia. 2008; 51(6):1035-40. PMC: 2362134. DOI: 10.1007/s00125-008-0992-1. View

Frykberg R, Belczyk R . Epidemiology of the Charcot foot. Clin Podiatr Med Surg. 2008; 25(1):17-28, v. DOI: 10.1016/j.cpm.2007.10.001. View

Fabrin J, Larsen K, Holstein P . Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000; 23(6):796-800. DOI: 10.2337/diacare.23.6.796. View

Herbst S, Jones K, Saltzman C . Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density. J Bone Joint Surg Br. 2004; 86(3):378-83. DOI: 10.1302/0301-620x.86b3.14593. View

Sohn M, Lee T, Stuck R, Frykberg R, Budiman-Mak E . Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009; 32(5):816-21. PMC: 2671113. DOI: 10.2337/dc08-1695. View

Abbott C, Malik R, van Ross E, Kulkarni J, Boulton A . Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011; 34(10):2220-4. PMC: 3177727. DOI: 10.2337/dc11-1108. View

Jeffcoate W . Charcot neuro-osteoarthropathy. Diabetes Metab Res Rev. 2008; 24 Suppl 1:S62-5. DOI: 10.1002/dmrr.837. View

Rajbhandari S, Jenkins R, Davies C, Tesfaye S . Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002; 45(8):1085-96. DOI: 10.1007/s00125-002-0885-7. View

Gouveri E, Papanas N . Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice. World J Diabetes. 2011; 2(5):59-65. PMC: 3116009. DOI: 10.4239/wjd.v2.i5.59. View

10.

Molines L, Darmon P, Raccah D . Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010; 36(4):251-5. DOI: 10.1016/j.diabet.2010.04.002. View

11.

Jeffcoate W, Game F, Cavanagh P . The role of proinflammatory cytokines in the cause of neuropathic osteoarthropathy (acute Charcot foot) in diabetes. Lancet. 2005; 366(9502):2058-61. DOI: 10.1016/S0140-6736(05)67029-8. View

12.

Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W . Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot). Diabet Med. 2004; 21(11):1243-6. DOI: 10.1111/j.1464-5491.2004.01215.x. View

13.

Ulbrecht J, Cavanagh P, Caputo G . Foot problems in diabetes: an overview. Clin Infect Dis. 2004; 39 Suppl 2:S73-82. DOI: 10.1086/383266. View

14.

Stuck R, Sohn M, Budiman-Mak E, Lee T, Weiss K . Charcot arthropathy risk elevation in the obese diabetic population. Am J Med. 2008; 121(11):1008-14. DOI: 10.1016/j.amjmed.2008.06.038. View

15.

Pakarinen T, Laine H, Maenpaa H, Mattila P, Lahtela J . Long-term outcome and quality of life in patients with Charcot foot. Foot Ankle Surg. 2009; 15(4):187-91. DOI: 10.1016/j.fas.2009.02.005. View

16.

Leung H, Ho Y, Wong W . Charcot foot in a Hong Kong Chinese diabetic population. Hong Kong Med J. 2009; 15(3):191-5. View

17.

Aragon-Sanchez J, Lazaro-Martinez J, Hernandez-Herrero M . Triggering mechanisms of neuroarthropathy following conservative surgery for osteomyelitis. Diabet Med. 2010; 27(7):844-7. DOI: 10.1111/j.1464-5491.2010.03019.x. View

18.

Frykberg R, Zgonis T, Armstrong D, Driver V, Giurini J, Kravitz S . Diabetic foot disorders. A clinical practice guideline (2006 revision). J Foot Ankle Surg. 2007; 45(5 Suppl):S1-66. DOI: 10.1016/S1067-2516(07)60001-5. View

19.

Papanas N, Maltezos E . Etiology, pathophysiology and classifications of the diabetic Charcot foot. Diabet Foot Ankle. 2013; 4. PMC: 3661901. DOI: 10.3402/dfa.v4i0.20872. View

20.

Nehring P, Mrozikiewicz-Rakowska B, Maroszek P, Sobczyk-Kopciol A, Krzyzewska M, Ploski R . Risk factors of charcot neuroarthropathy development in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes. 2013; 122(1):31-4. DOI: 10.1055/s-0033-1358483. View